AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

264.260

-0.450-0.17%

Volume:855.41K

Turnover:225.85M

Market Cap:127.96B

PE:29.58

High:265.300

Open:264.000

Low:262.230

Close:264.710

Loading ...

Overview Company News Filings

Flu Vaccines Proving Problematic for CSL -- Market Talk

Everything you need to know about the latest CSL dividend

What are brokers saying about CSL shares after the selloff?

Is CSL undervalued after earnings season wobble?

Morning Star AU

CSL falls short, despite $8.48 billion revenue

Australian Shares Flat as Trump Orders Tariffs; CSL Posts Higher Fiscal H1 Earnings

MT Newswires Live

Australian shares end flat as CSL's decline offsets gold stocks' rally

ASX Market Close: Bourse trades flat as Trumps flags possible tariff exemptions | February 11, 2025

The Market Herald

BUZZ-Australia's CSL slips to 14-1/2-month low on first-half profit miss

ASX Midday Sector Update: Utilities Stocks Rise, Healthcare Struggles

MT Newswires Live

Market Chatter: CSL Fiscal First-Half Results Misses Expectations, Barrenjoey Says

MT Newswires Live

Shining gold stocks lead Australian shares higher

CSL up 6% on strong demand for CSL Behring business

The Market Herald

CSL says on track for double-digit growth but vaccine sales weak

The Australian Financial Review

CSL Posts Higher Fiscal H1 Earnings, Revenue; Reaffirms Outlook

MT Newswires Live

CSL share price on watch amid $2.1b half year profit and dividend hike

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":264.26,"timestamp":1741151520000,"preClose":264.71,"halted":0,"volume":855410,"delay":0,"changeRate":-0.0017,"change":-0.45,"floatShares":483945244,"shares":484206716,"eps":8.933219,"lyrEps":8.628758,"pbRate":4.37,"amount":225853379,"amplitude":0.011598,"volumeRatio":0.8830963053667806,"dividePrice":4.338155,"prevYearClose":281.58,"fiveDayClose":264.82,"twentyDayClose":270.34},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483945244,"roa":"6.61%","roe":"14.35%","lyrEps":8.628758,"volumeRatio":0.8830963053667806,"shares":484206716,"dividePrice":4.338155,"high":265.3,"amplitude":0.011598,"preClose":264.71,"low":262.23,"week52Low":253.04,"pbRate":"4.37","psRate":"5.33","week52High":311.319,"institutionHeld":0,"latestPrice":264.26,"eps":8.933219226704106,"divideRate":0.016497,"volume":855410,"delay":0,"ttmEps":8.933219226704106,"open":264,"prevYearClose":281.58,"prevWeekClose":260.57,"prevMonthClose":260.57,"prevQuarterClose":281.58,"fiveDayClose":264.82,"twentyDayClose":270.34,"sixtyDayClose":281.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","defaultRemindTime":1741561200000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510365073","title":"Flu Vaccines Proving Problematic for CSL -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2510365073","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510365073?lang=en_us&edition=fundamental","pubTime":"2025-02-12 06:30","pubTimestamp":1739313000,"startTime":"0","endTime":"0","summary":"2230 GMT - CSL's vaccines business is in need of a shot in the arm. UBS says CSL's Seqirus unit missed its 1H revenue forecast by 6% as U.S. demand weakened again. Analyst Laura Sutcliffe thinks elevated flu cases in FY 2025 will drive a recovery in immunization rates the following year, but probably not back to FY 2024 levels. \"In general, margins tend to scale with sales in vaccines,\" UBS says. Government contracts for H5  pandemic readiness are a bright spot. UBS estimates revenue from these contracts at US$150 million in 2H, building on an estimated in US$60 million in 1H. Still, UBS believes the percentage drop in FY 2025 vaccine sales will be in the mid-to-high teens when these contracts are excluded. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0728928796.USD","BK7511","BK7508","BK7067","LU1169590202.USD","BK4086","BK7501","CSL","SG9999004303.SGD","LU1169589451.USD","CSL.AU","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2510365984","title":"Everything you need to know about the latest CSL dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2510365984","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510365984?lang=en_us&edition=fundamental","pubTime":"2025-02-12 06:15","pubTimestamp":1739312143,"startTime":"0","endTime":"0","summary":"Yesterday, we got one of the first earnings reports of the season from a major blue chip share. That blue chip share was healthcare stock CSL Ltd (ASX: CSL). We discussed all of the major details at t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/12/everything-you-need-to-know-about-the-latest-csl-dividend-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","CSL.AU","SGXZ23171101.USD","SG9999004303.SGD","CSL","LU0728928796.USD","LU1169589451.USD","BK7501","BK4086","BK7067","LU1169590202.USD","BK7511"],"gpt_icon":0},{"id":"2510401363","title":"What are brokers saying about CSL shares after the selloff?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510401363","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510401363?lang=en_us&edition=fundamental","pubTime":"2025-02-12 05:11","pubTimestamp":1739308265,"startTime":"0","endTime":"0","summary":"CSL Ltd  shares were under pressure on Tuesday. Despite initially charging higher following the release of its half year results, the biotechnology giant's shares ultimately ended the session with a 5% decline to $256.96. While this was disappointing, has it created a buying opportunity?Let's see what two leading brokers are saying. Are CSL shares a top buy?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/12/what-are-brokers-saying-about-csl-shares-after-the-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00BSNM7G36.USD","BK4533","LU2237443382.USD","LU2237443549.SGD","BK7508","BK4588","BK4516","BK4585","IE00B19Z3B42.SGD","SG9999004303.SGD","CSL.AU","IE0002270589.USD","IE0004091025.USD","BK7511","LU0106831901.USD","BK4127","LU2237443895.HKD","LU1791807156.HKD","BK4552","BK7067","BK4504","IE0004086264.USD","IE0034235188.USD","IE00BFXG1179.USD","BK4086","LU1169589451.USD","BK4550","LU0728928796.USD","IE00B19Z3581.USD","CSL","LU2237443622.USD","LU1169590202.USD","SGXZ23171101.USD","LU2237443465.HKD","LU2237443978.SGD","LU1668664300.SGD","LU2237438978.USD","BK7501"],"gpt_icon":0},{"id":"2511641425","title":"Is CSL undervalued after earnings season wobble?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511641425","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511641425?lang=en_us&edition=fundamental","pubTime":"2025-02-12 00:00","pubTimestamp":1739289600,"startTime":"0","endTime":"0","summary":"Narrow-moat CSL (CSL) reiterated fiscal 2025 guidance for constant-currency group net profit after tax before amortization, or NPATA, of USD 3.2 billion to USD 3.3 billion, implying 10-13% growth on f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/insights/stocks/260757/is-csl-undervalued-after-earnings-season-wobble","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["CSL","CSL.AU"],"gpt_icon":0},{"id":"2510795808","title":"CSL falls short, despite $8.48 billion revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2510795808","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510795808?lang=en_us&edition=fundamental","pubTime":"2025-02-11 14:18","pubTimestamp":1739254681,"startTime":"0","endTime":"0","summary":"Only a few short years ago, we watched the greatest global vaccination drive in living history take place. It seems ironic therefore that vaccinations are behind CSL’s reporting miss this season. Though, perhaps it’s simply a matter of ongoing post-pandemic fatigue and apathy - or related to US politics. It’s not been a mild flu season to account for lower rates – in fact, the flu has peaked twice in the US and there has been rising hospitalisation in some states.CSL Seqirus, the vaccination segment, was affected by low influenza vaccination rates in the US, dragging down overall revenue. By contrast, the crown jewel, plasma business CSL Behring, continued to offer strength with 10% growth in revenue. Even iron deficiency and anaemia business CSL Vifor had positive growth in its revenue, though analysts remain sceptical of the price CSL paid for it.CSL revenue breakdown. Source: CSL FY25 half-year results presentation. up 5% to $8.48 billion vs. $8.54 consensus ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/csl-falls-short-despite-8-48-billion-revenue","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/csl-falls-short-despite-8-48-billion-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["CSL.AU","CSL"],"gpt_icon":0},{"id":"2510382256","title":"Australian Shares Flat as Trump Orders Tariffs; CSL Posts Higher Fiscal H1 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2510382256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510382256?lang=en_us&edition=fundamental","pubTime":"2025-02-11 14:12","pubTimestamp":1739254346,"startTime":"0","endTime":"0","summary":"Australian shares were flat with a positive bias on Tuesday's close, despite declines in Wall Street and other Asian markets, after Trump ordered 25% tariffs on all steel and aluminum imports while hi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","CSL","XJO.AU","RHC.AU","BRG.AU","XKO.AU","XAO.AU"],"gpt_icon":0},{"id":"2510511824","title":"Australian shares end flat as CSL's decline offsets gold stocks' rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2510511824","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510511824?lang=en_us&edition=fundamental","pubTime":"2025-02-11 13:54","pubTimestamp":1739253255,"startTime":"0","endTime":"0","summary":"Australian shares end flat as CSL's decline offsets gold stocks' rallyGold stocks scale fresh peakLithium stocks fall on reports of CATL restarting productionNine Entertainment top gainer on ASX 200By Roshan Thomas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL4N3P206T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0788109121.HKD","BHP.AU","BK7095","BK7052","LU0266512127.USD","LU0456854461.SGD","FMG.AU","LU0898667661.SGD","BK7507","SG9999001143.SGD","SWM.AU","BK7511","LU1130305938.SGD","NEC.AU","LU1023059493.AUD","LU1430597077.USD","LU0630314457.HKD","LU0345777147.USD","CSL.AU","RIO.UK","SG9999002521.SGD","LU0075056555.USD","LU0612318385.USD","LU1064927863.SGD","IE00BQJZX424.USD","LU0654597011.USD","LU0330918003.SGD","BK7129","LU0011963245.USD","LU1078025761.USD","BK7508","LU0345780950.USD","NST.AU","LU0505663152.USD","BK7506","BK7104","IE00BWDBJ516.SGD","BK7067","BK7501","LU0171293334.USD","LU0345777659.USD","IE0034235071.USD","LU0345781412.USD","IE00B3M56506.USD","LU0612318971.USD","LU0831103253.SGD","BK5111","LU0955669360.SGD"],"gpt_icon":0},{"id":"2510804980","title":"ASX Market Close: Bourse trades flat as Trumps flags possible tariff exemptions | February 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510804980","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510804980?lang=en_us&edition=fundamental","pubTime":"2025-02-11 13:43","pubTimestamp":1739252580,"startTime":"0","endTime":"0","summary":"The Aussie bourse pared early gains after lifts in companies posting positive results were offset by a large sell-off in index giant CSL .Trump has indicated he’s considering applying a tariff exemption to Aussie steel and aluminium. The move came after a call between Albanese and Trump.Gold has hit an all-time high of $2,924 per ounce as investors flock to the safe haven asset.Industrials was the best-performing sector, up 1%, followed by IT, up 0.9% and Telecommunication, up 0.75%.Solis Minerals closed up 49.2% after confirming extensive copper mineralisation at its Cinto Project in southernPeru.CSL closed down 4.9% after posting financial results for the half-year ending December 31, 2024, highlighting robust growth across key segments. The company’s overall revenue increased by 5%, reaching $8.43 billion, while net profit after tax grew by 7%.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to condu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-bourse-trades-flat-as-trumps-flags-possible-tariff-exemptions-february-11-2025-2025-02-11/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["CSL.AU","BK7142","WC8.AU","EXR.AU","ALC.AU","BK7508","SLM.AU","BK7506","BK7501","BK7067","BK7511","BK7095","BK7104","KNB.AU","BK7094"],"gpt_icon":0},{"id":"2510678823","title":"BUZZ-Australia's CSL slips to 14-1/2-month low on first-half profit miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2510678823","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510678823?lang=en_us&edition=fundamental","pubTime":"2025-02-11 12:13","pubTimestamp":1739247204,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL slips to 14-1/2-month low on first-half profit miss** Shares of CSL CSL.AX fall as much as 5.5% to A$255.4, their lowest levels since November 21, 2023 ** The biopharmaceutical co has reported half-year net profit of $2.01 billion, lower than analysts' forecast of $2.09 billion** Co says earnings weighed down by falling immunisation rates in the U.S., its largest market** About 1.2 million shares change hands, vs the 30-day average of 558,040** Stock fell 1.8% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL4N3P2098:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2510844701","title":"ASX Midday Sector Update: Utilities Stocks Rise, Healthcare Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2510844701","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510844701?lang=en_us&edition=fundamental","pubTime":"2025-02-11 10:43","pubTimestamp":1739241800,"startTime":"0","endTime":"0","summary":"Utilities stocks continued a strong streak, advancing past 1.1% at midday Tuesday, as investors switched to defensive stocks.De.mem  signed a nonexclusive strategic distribution agreement for its standardized filtration systems with Firmbase Singapore, targeting China, Indonesia, and Japan.Meanwhile, healthcare fell more than 1.5%, the only sector in the red, dragged down by index heavyweight CSL , which fell over 2%.CSL's revenue for the six months ended Dec. 31, 2024, was $8.48 billion, up from $8.05 billion in the same period a year earlier. Analysts surveyed by Visible Alpha expected $8.54 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","BK4137","BK7067","BK7100","DEM.AU","BK7501","BK7508","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2510844171","title":"Market Chatter: CSL Fiscal First-Half Results Misses Expectations, Barrenjoey Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2510844171","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510844171?lang=en_us&edition=fundamental","pubTime":"2025-02-11 10:35","pubTimestamp":1739241320,"startTime":"0","endTime":"0","summary":"CSL's (ASX:CSL) fiscal first-half adjusted net profit after tax (NPAT) of $2.07 billion fell 4% below estimates by Visible Alpha of $2.16 billion, The Australian reported Tuesday, citing investment ba","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0728928796.USD","LU1169589451.USD","BK7508","BK7067","BK7511","LU1169590202.USD","CSL","BK7501","SG9999004303.SGD","BK4086","CSL.AU","SGXZ23171101.USD"],"gpt_icon":0},{"id":"2510810761","title":"Shining gold stocks lead Australian shares higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2510810761","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510810761?lang=en_us&edition=fundamental","pubTime":"2025-02-11 08:39","pubTimestamp":1739234341,"startTime":"0","endTime":"0","summary":"Shining gold stocks lead Australian shares higher Feb 11 (Reuters) - Australian shares rose on Tuesday, as gold miners hit an all-time high after the bullion's record rally, while other sectors also g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL4N3P200N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7031","BK7046","BK7135","CSL.AU","MQG.AU","BK7511","BK7501","BK7506","BK7120","BK7067","CBA.AU","BK7104","SGH.AU","WBC.AU","BK7508","EVN.AU","NST.AU"],"gpt_icon":0},{"id":"2510812157","title":"CSL up 6% on strong demand for CSL Behring business","url":"https://stock-news.laohu8.com/highlight/detail?id=2510812157","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510812157?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:36","pubTimestamp":1739226960,"startTime":"0","endTime":"0","summary":"CSL Ltd  has seen its net profits rise by 6% in the first half of the 2025 fiscal year, driven by growing revenue from its CSL Behring business, which is responsible for plasma products and gene therapies.The company’s net profit after tax had risen 6% to US$2.01 billion  during 1H FY2025, with revenue rising by 5% to US$8.48B, and net guidance on track – remaining between US$3.2B and US$3.3B.“CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring,” CEO and managing director Dr Paul McKenzie said, adding this was just one arm in which customer demand was evident.“CSL Seqirus was negatively impacted by significantly low influenza immunisation rates, particularly in the U.S. CSL Vifor grew sales, underpinned by robust iron volumes in Europe and the expansion of our nephrology products.”CSL’s interim dividend was US$1.30 per share , a rise of 16%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/csl-up-6-on-strong-demand-for-csl-behring-business-2025-02-11/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["LU1169589451.USD","LU0728928796.USD","BK4086","CSL","BK7508","BK7067","LU1169590202.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7501","CSL.AU","BK7511"],"gpt_icon":1},{"id":"2510099816","title":"CSL says on track for double-digit growth but vaccine sales weak","url":"https://stock-news.laohu8.com/highlight/detail?id=2510099816","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510099816?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:19","pubTimestamp":1739225940,"startTime":"0","endTime":"0","summary":"CSL says low immunisation rates in the United States hurt first-half sales for its vaccination business but a solid result for its core blood plasma business meant it still expected to deliver double-digit earnings growth this year.The pharmaceutical giant said on Tuesday first-half net profit rose 7 per cent to $US2.01 billion  after revenues lifted 5 per cent to $US8.48 billion. It declared an interim dividend of $US130 per share, up 9 per cent.Loading...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/companies/healthcare-and-fitness/csl-says-on-track-for-double-digit-growth-but-vaccine-sales-weak-20250210-p5lb0u","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["CSL","CSL.AU"],"gpt_icon":1},{"id":"2510081329","title":"CSL Posts Higher Fiscal H1 Earnings, Revenue; Reaffirms Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2510081329","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510081329?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:49","pubTimestamp":1739224150,"startTime":"0","endTime":"0","summary":"CSL  reported Tuesday that its earnings per diluted share in the fiscal half rose to $4.13 from $3.92 per diluted share a year earlier.Analysts polled by Visible Alpha were expecting an EPS of $4.24.Revenue for the six months ended Dec. 31, 2024, was $8.48 billion, up from $8.05 billion in the same period a year earlier. Analysts surveyed by Visible Alpha expected $8.54 billion.The company reaffirmed its previous guidance for fiscal 2025 of revenue growth in the range of 5% to 7% and adjusted net profit after tax to be in the range of $3.2 billion to $3.3 billion. Analysts polled by Visible Alpha expect EPS of $6.28 on revenue of $15.75 billion.The board declared an interim dividend of $1.30 per share, down from the $1.19 in the previous reported period, payable on April 9 to shareholders on record as of March 11.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","CSL"],"gpt_icon":0},{"id":"2510811586","title":"CSL share price on watch amid $2.1b half year profit and dividend hike","url":"https://stock-news.laohu8.com/highlight/detail?id=2510811586","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510811586?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:48","pubTimestamp":1739224108,"startTime":"0","endTime":"0","summary":"The CSL Ltd  share price will be one to watch closely today. That's because the biotechnology giant has just released its half year results. Let's see how the widely followed company reported. CSL share price on watch following results release  Revenue up 5% in constant currency to US$8.48 billion Net profit after tax up 7% in constant currency to US$2.04 billion NPATA up 5% in constant currency to US$2.11 billion Reported NPATA up 3% to US$2.07 billion Interim dividend of US$1.30 per share  What happened during the half?This result appears to have fallen short of expectations, which could potentially be bad news for the CSL share price today. Goldman Sachs was forecasting total revenue of US$8.66 billion and NPATA of US$2.27 billion .Whereas it reported revenue of revenue of US$8.48 billion and constant curr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/11/csl-share-price-on-watch-amid-2-1b-half-year-profit-and-dividend-hike/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL.AU","BK7511","BK4086","LU0728928796.USD","BK7508","LU1169590202.USD","BK7501","SGXZ23171101.USD","BK7067","CSL","LU1169589451.USD","SG9999004303.SGD"],"gpt_icon":1}],"pageSize":16,"totalPage":13,"pageCount":3,"totalSize":200}]}}